Suppression of ERR targets by a PPARα/Sirt1 complex in the failing heart

Cell Cycle

Volumn 11, Issue 5, 2012, Pages 856-864

  Oka, Shin Ichi ^a   Zhai, Peiyong ^a   Alcendor, Ralph ^a   Park, Ji Yeon ^b   Tian, Bin ^b   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Estrogenrelated receptor (ERR); Heart failure; Nuclear encoded mitochondrial gene; Peroxisome proliferatoractivated receptor alpha (PPAR ); Silent information regulator 1 (Sirt1); Transcriptional control

Indexed keywords

ESTROGEN RELATED RECEPTOR ALPHA; HISTONE DEACETYLASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID TRANSFER PROTEIN; PIRINIXIC ACID; RETINOID X RECEPTOR ALPHA; SIRTUIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ESTROGEN RESPONSIVE ELEMENT; GENE REPRESSION; GENE TARGETING; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSVERSE AORTIC CONSTRICTION;

MUS;

EID: 84863274313     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.5.19210     Document Type: Article

References (31)

1. Glass CK. Going nuclear in metabolic and cardiovascular disease. J Clin Invest 2006; 116:556- 60; PMID:16511587; http://dx.doi.org/10.1172/JCI27913.
2. Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 2006; 6:44-55; PMID:16493426; http://dx.doi.org/10.1038/nri1748.
3. Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res 2004; 95:568- 78; PMID:15375023; http://dx.doi.org/10.1161/01.RES. 0000141774.29937.e3.
4. Cotnoir-White D, Laperrière D, Mader S. Evolution of the repertoire of nuclear receptor binding sites in genomes. Mol Cell Endocrinol 2011; 334:76-82; PMID:21056084; http://dx.doi.org/10.1016/j.mce.2010.10.021.
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835-9; PMID:8521507; http://dx.doi.org/10.1016/0092-8674(95)90199-X.
6. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab 2007; 5:345-56; PMID:17488637; http://dx.doi.org/10.1016/j.cmet.2007.03.007.
7. Sladek R, Bader JA, Giguère V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 1997; 17:5400-9; PMID:9271417.
8. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F, Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res 2010; 106:1541-8; PMID:20339121; http://dx.doi.org/10.1161/ CIRCRESAHA.109.212753.
9. Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 2009; 46:201-12; PMID:19061896; http://dx.doi.org/10.1016/j.yjmcc. 2008.10.025.
10. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37:907-25; PMID:8725145.
11. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, et al. Structure of the intact PPARgamma-RXR-nuclear receptor complex on DNA. Nature 2008; 456:350-6; PMID:19043829; http://dx.doi.org/10.1038/nature07413.
12. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83:841-50; PMID:8521508; http://dx.doi.org/10.1016/0092-8674(95)90200-7.
13. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010; 5:253-95; PMID:20078221; http://dx.doi.org/10.1146/annurev.pathol.4.110807.092250.
14. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009; 9:327-38; PMID:19356714; http://dx.doi.org/10.1016/j. cmet.2009.02.006.
15. Oka S, Alcendor R, Zhai P, Park JY, Shao D, Cho J, et al. PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab 2011; 14:598-611; PMID:22055503; http://dx.doi.org/10.1016/j. cmet.2011.10.001.
16. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, et al. Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 2008; 22:2953-67; PMID:18981474; http://dx.doi.org/10.1101/gad.501108.
17. van der Meer DL, Degenhardt T, Väisänen S, de Groot PJ, Heinäniemi M, de Vries SC, et al. Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res 2010; 38:2839-50; PMID:20110263; http://dx.doi.org/10.1093/nar/gkq012.
18. Tu AY, Albers JJ. DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate. Biochem Biophys Res Commun 1999; 264:802-7; PMID:10544012; http://dx.doi.org/10.1006/bbrc.1999.1597.
19. Miyazaki M, Nakagawa I, Koga S, Kasahara Y, Patricelli MP. Proteomics analysis of cardiac muscle from rats with peroxisomal proliferator-activated receptor alpha (PPARalpha) stimulation. J Toxicol Sci 2010; 35:131-5; PMID:20118634; http://dx.doi.org/10.2131/jts.35.131.
20. Cantó C, Auwerx J. Interference between PARPs and SIRT1: a novel approach to healthy ageing? Aging (Albany NY) 2011; 3:543-7; PMID:21566260.
21. Pardo PS, Boriek AM. The physiological roles of Sirt1 in skeletal muscle. Aging (Albany NY) 2011; 3:430-7; PMID:21483036.
22. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1alpha. J Biol Chem 2005; 280:16456-60; PMID:15716268; http://dx.doi.org/10.1074/jbc.M501485200.
23. Mathiyalagan P, Chang L, Du XJ, El-Osta A. Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle 2010; 9:612-7; PMID:20090419; http://dx.doi.org/10.4161/cc.9.3.10612.
24. Karagiannis TC, Lin AJ, Ververis K, Chang L, Tang MM, Okabe J, et al. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging (Albany NY) 2010; 2:659-68; PMID:20930262.
25. McKenna NJ, Cooney AJ, DeMayo FJ, Downes M, Glass CK, Lanz RB, et al. Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Mol Endocrinol 2009; 23:740-6; PMID:19423650; http://dx.doi.org/10.1210/me.2009- 0135.
26. Yen WL, Klionsky DJ. How to live long and prosper: autophagy, mitochondria and aging. Physiology (Bethesda) 2008; 23:248-62; PMID:18927201; http://dx.doi.org/10.1152/physiol.00013.2008.
27. Enns LC, Pettan-Brewer C, Ladiges W. Protein kinase A is a target for aging and the aging heart. Aging (Albany NY) 2010; 2:238-43; PMID:20448293.
28. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007; 100:1512-21; PMID:17446436; http://dx.doi.org/10.1161/01.RES.0000267723.65696. 4a.
29. Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122:2170-82; PMID:21060073; http://dx.doi.org/10.1161/ CIRCULATIONAHA.110.958033.
30. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010; 2:914-23; PMID:21212461.
31. Chodorowski Z, Rybakowska I, Anand JS, Kaletha K. Energy metabolism in the failing heart. Przegl Lek 2009; 66:356-8; PMID:19788151.